LumiraDx Analyst Ratings
LumiraDx Analyst Ratings
While ratings are subjective and will change, the latest LumiraDx (LMDX) rating was a maintained with a price target of $4.00 to $3.50. The current price LumiraDx (LMDX) is trading at is $1.07, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/11/2022 | 227.1% | Raymond James | $4 → $3.5 | Maintains | Outperform |
| 08/19/2022 | 273.83% | BTIG | $7 → $4 | Maintains | Buy |
| 08/19/2022 | 273.83% | Raymond James | $7 → $4 | Maintains | Outperform |
| 05/12/2022 | 1208.41% | Ladenburg Thalmann | $15.25 → $14 | Maintains | Buy |
| 05/12/2022 | 554.21% | Raymond James | $9 → $7 | Maintains | Outperform |
| 03/11/2022 | 741.12% | Raymond James | $13 → $9 | Maintains | Outperform |
| 11/15/2021 | 1769.16% | Evercore ISI Group | → $20 | Initiates Coverage On | → Outperform |
| 10/25/2021 | 1114.95% | Raymond James | → $13 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/11/2022 | 227.1% | 雷蒙德·詹姆 | 4 美元 → 3.5 美元 | 維護 | 跑贏大盤 |
| 2022 年 8 月 19 日 | 273.83% | BTIG | 7 美元 → 4 美元 | 維護 | 買 |
| 2022 年 8 月 19 日 | 273.83% | 雷蒙德·詹姆 | 7 美元 → 4 美元 | 維護 | 跑贏大盤 |
| 05/12/2022 | 1208.41% | 拉登堡塔爾曼 | 15.25 美元 → 14 美元 | 維護 | 買 |
| 05/12/2022 | 554.21% | 雷蒙德·詹姆 | 9 美元 → 7 美元 | 維護 | 跑贏大盤 |
| 03/11/2022 | 741.12% | 雷蒙德·詹姆 | 13 美元 → 9 美元 | 維護 | 跑贏大盤 |
| 11/15/2021 | 1769.16% | Evercore ISI 集團 | → 20 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 2021 年 10 月 25 日 | 1114.95% | 雷蒙德·詹姆 | → 13 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
LumiraDx Questions & Answers
LumiRadX 問題與解答
The latest price target for LumiraDx (NASDAQ: LMDX) was reported by Raymond James on November 11, 2022. The analyst firm set a price target for $3.50 expecting LMDX to rise to within 12 months (a possible 227.10% upside). 7 analyst firms have reported ratings in the last year.
雷蒙德·詹姆斯於2022年11月11日公佈了LumiRadX（納斯達克股票代碼：LMDX）的最新目標股價。該分析公司將目標股價定爲3.50美元，預計LMDX將在12個月內升至12個月內（可能上漲227.10％）。去年有7家分析公司公佈了評級。
The latest analyst rating for LumiraDx (NASDAQ: LMDX) was provided by Raymond James, and LumiraDx maintained their outperform rating.
LumiRadX（納斯達克股票代碼：LMDX）的最新分析師評級由雷蒙德·詹姆斯提供，LumiRadX維持跑贏大盤評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LumiraDx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LumiraDx was filed on November 11, 2022 so you should expect the next rating to be made available sometime around November 11, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與LumiRadx的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。LumiRadx的最新評級是在2022年11月11日公佈的，因此您應該預計下一個評級將在2023年11月11日左右公佈。
While ratings are subjective and will change, the latest LumiraDx (LMDX) rating was a maintained with a price target of $4.00 to $3.50. The current price LumiraDx (LMDX) is trading at is $1.07, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的LumiRadX（LMDX）評級保持不變，目標股價爲4.00美元至3.50美元。LumiRadX（LMDX）目前的交易價格爲1.07美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。
